Shedding Light on the Elephant in a Dark Room in the Discovery of New Medicine: Highlighting Molecular Pharmaceutics within ACS Bio & Med Chem Au

IF 3.8 Q2 BIOCHEMISTRY & MOLECULAR BIOLOGY
Afsaneh Lavasanifar*,  and , Lynne S. Taylor, 
{"title":"Shedding Light on the Elephant in a Dark Room in the Discovery of New Medicine: Highlighting Molecular Pharmaceutics within ACS Bio & Med Chem Au","authors":"Afsaneh Lavasanifar*,  and , Lynne S. Taylor, ","doi":"10.1021/acsbiomedchemau.2c00047","DOIUrl":null,"url":null,"abstract":"T parable of the “Blind men and an elephant” is a famous story in many cultures around the world. The story, which originated in the ancient Indian subcontinent, was retold by Rumi, the 13th century Persian poet, in a poem named “The elephant in the dark room”. In the 19th century, the American poet John Godfrey Saxe made his own poem based on the story (The poems of John Godfrey Saxe/The Blind Men and the Elephant). The story tells us about six blind men, who have not seen an elephant before, approaching one in a dark room. They try to learn what the elephant is like by touching it. Each man feels a different part of the elephant’s body (its side, tusk, trunk etc.) and describes it based on their experience, which of course is different from the description of others and far from reality or the big picture. This tale is a great metaphor for the limitations of isolated scientific observation in the development of real and accurate knowledge and/or the translation of discoveries into impactful solutions for real-life problems. Reflecting on the lessons learned from this tale, as applied to the scientific world, reminds us of the need for a multidisciplinary and collaborative approach for producing impactful research, and this is particularly true for the drug development process. A medicine is much more than a molecule and its development requires contributions from different scientific disciplines including, but not limited to, medicinal and analytical chemists, biologists, and formulation scientists. The key to life-changing new discoveries in drug development is in the communication and exchange of ideas between scientific teams from these different disciplines. Recognizing the need for a fully open access, multidisciplinary scientific communication platform, particularly for scientists working in drug development, has led the American Chemical Society to launch ACS Bio & Med Chem Au. The journal, which is one of the nine gold (Au) open access journals, has a broad scope and showcases research from biological, medicinal, and pharmaceutical sciences to nurture communication and information sharing between scientists from different but related disciplines, and this is hugely useful for drug development research. ACS Bio & Med Chem Au particularly recognizes the importance of the molecular and mechanistic understanding of drug formulations as well as translational research in areas of pharmaceutical chemistry, existing and emerging drug delivery systems, biological performance of formulations, and other multidisciplinary research projects, especially those in the field of pharmaceutical development which are within the scope of Molecular Pharmaceutics. In this context, the journal welcomes submission of Articles, Letters, Perspectives, and Reviews with a focus on understanding the physicochemical properties of drugs and drug formulations (including small molecules, proteins, and genes) affecting their in vitro/in vivo function, the development of biological or bioinspired or synthetic delivery systems for current and future medicine, as well as translational research within the field of drug development. Our goal is to encourage the sharing and communication of ideas between different disciplines involved in the drug development process to better understand scientific observations and their translation to real-life solutions for healthrelated problems. The fact that the journal is fully open access further improves accessibility to those in industry, academia, as well as the general public. Without a doubt, the rate of research advancement and new discoveries within the biomedical field has witnessed exponential growth within the past few decades. The development of new biochemical and analytical tools enabling the elucidation of molecular mechanisms behind observations in biological systems has played a critical role in this growth. Collaborative and/or multidisciplinary research has also played a decisive part in the advancement of research and led to many groundbreaking scientific developments. It is no coincidence that the Nobel Prize in Physics, Chemistry, and Physiology and Medicine, particularly in the past four decades, has often been awarded to multiple scientists, each playing a complementary role in an important discovery or translation of the discovery to an intervention that can change human lives. In many instances, these scientists made their contributions a few years or decades apart. For instance, the 1984 noble prize in Physiology and Medicine was awarded to Niels K. Jerne, Georges J. F. Köhler, and Ceśar Milstein “for theories concerning the specificity in development and control of the immune system and the discovery of the principle for production of monoclonal antibodies”. These scientists made their individual contributions to the idea of specificity","PeriodicalId":29802,"journal":{"name":"ACS Bio & Med Chem Au","volume":"2 4","pages":"313–315"},"PeriodicalIF":3.8000,"publicationDate":"2022-08-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://pubs.acs.org/doi/epdf/10.1021/acsbiomedchemau.2c00047","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"ACS Bio & Med Chem Au","FirstCategoryId":"1085","ListUrlMain":"https://pubs.acs.org/doi/10.1021/acsbiomedchemau.2c00047","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"BIOCHEMISTRY & MOLECULAR BIOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

T parable of the “Blind men and an elephant” is a famous story in many cultures around the world. The story, which originated in the ancient Indian subcontinent, was retold by Rumi, the 13th century Persian poet, in a poem named “The elephant in the dark room”. In the 19th century, the American poet John Godfrey Saxe made his own poem based on the story (The poems of John Godfrey Saxe/The Blind Men and the Elephant). The story tells us about six blind men, who have not seen an elephant before, approaching one in a dark room. They try to learn what the elephant is like by touching it. Each man feels a different part of the elephant’s body (its side, tusk, trunk etc.) and describes it based on their experience, which of course is different from the description of others and far from reality or the big picture. This tale is a great metaphor for the limitations of isolated scientific observation in the development of real and accurate knowledge and/or the translation of discoveries into impactful solutions for real-life problems. Reflecting on the lessons learned from this tale, as applied to the scientific world, reminds us of the need for a multidisciplinary and collaborative approach for producing impactful research, and this is particularly true for the drug development process. A medicine is much more than a molecule and its development requires contributions from different scientific disciplines including, but not limited to, medicinal and analytical chemists, biologists, and formulation scientists. The key to life-changing new discoveries in drug development is in the communication and exchange of ideas between scientific teams from these different disciplines. Recognizing the need for a fully open access, multidisciplinary scientific communication platform, particularly for scientists working in drug development, has led the American Chemical Society to launch ACS Bio & Med Chem Au. The journal, which is one of the nine gold (Au) open access journals, has a broad scope and showcases research from biological, medicinal, and pharmaceutical sciences to nurture communication and information sharing between scientists from different but related disciplines, and this is hugely useful for drug development research. ACS Bio & Med Chem Au particularly recognizes the importance of the molecular and mechanistic understanding of drug formulations as well as translational research in areas of pharmaceutical chemistry, existing and emerging drug delivery systems, biological performance of formulations, and other multidisciplinary research projects, especially those in the field of pharmaceutical development which are within the scope of Molecular Pharmaceutics. In this context, the journal welcomes submission of Articles, Letters, Perspectives, and Reviews with a focus on understanding the physicochemical properties of drugs and drug formulations (including small molecules, proteins, and genes) affecting their in vitro/in vivo function, the development of biological or bioinspired or synthetic delivery systems for current and future medicine, as well as translational research within the field of drug development. Our goal is to encourage the sharing and communication of ideas between different disciplines involved in the drug development process to better understand scientific observations and their translation to real-life solutions for healthrelated problems. The fact that the journal is fully open access further improves accessibility to those in industry, academia, as well as the general public. Without a doubt, the rate of research advancement and new discoveries within the biomedical field has witnessed exponential growth within the past few decades. The development of new biochemical and analytical tools enabling the elucidation of molecular mechanisms behind observations in biological systems has played a critical role in this growth. Collaborative and/or multidisciplinary research has also played a decisive part in the advancement of research and led to many groundbreaking scientific developments. It is no coincidence that the Nobel Prize in Physics, Chemistry, and Physiology and Medicine, particularly in the past four decades, has often been awarded to multiple scientists, each playing a complementary role in an important discovery or translation of the discovery to an intervention that can change human lives. In many instances, these scientists made their contributions a few years or decades apart. For instance, the 1984 noble prize in Physiology and Medicine was awarded to Niels K. Jerne, Georges J. F. Köhler, and Ceśar Milstein “for theories concerning the specificity in development and control of the immune system and the discovery of the principle for production of monoclonal antibodies”. These scientists made their individual contributions to the idea of specificity
在新药物的发现中照亮黑暗房间里的大象:在ACS生物与医学化学Au中突出分子药物
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
ACS Bio & Med Chem Au
ACS Bio & Med Chem Au 药物、生物、化学-
CiteScore
4.10
自引率
0.00%
发文量
0
期刊介绍: ACS Bio & Med Chem Au is a broad scope open access journal which publishes short letters comprehensive articles reviews and perspectives in all aspects of biological and medicinal chemistry. Studies providing fundamental insights or describing novel syntheses as well as clinical or other applications-based work are welcomed.This broad scope includes experimental and theoretical studies on the chemical physical mechanistic and/or structural basis of biological or cell function in all domains of life. It encompasses the fields of chemical biology synthetic biology disease biology cell biology agriculture and food natural products research nucleic acid biology neuroscience structural biology and biophysics.The journal publishes studies that pertain to a broad range of medicinal chemistry including compound design and optimization biological evaluation molecular mechanistic understanding of drug delivery and drug delivery systems imaging agents and pharmacology and translational science of both small and large bioactive molecules. Novel computational cheminformatics and structural studies for the identification (or structure-activity relationship analysis) of bioactive molecules ligands and their targets are also welcome. The journal will consider computational studies applying established computational methods but only in combination with novel and original experimental data (e.g. in cases where new compounds have been designed and tested).Also included in the scope of the journal are articles relating to infectious diseases research on pathogens host-pathogen interactions therapeutics diagnostics vaccines drug-delivery systems and other biomedical technology development pertaining to infectious diseases.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信